Borosil Scientific growth ratios

Per cent unless marked ×
Tap a line for its trendFY26Mar 2026
+6.6%
+18.3%
+25.9%
+29.4%
+28.8%
+7.9%
+9.1%
−64.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BOROSCI₹105.00

Borosil Scientific Limited

· Capital Goods & Defence
₹ CrorePeersSEJALLTDMcap ₹934 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Revenue Growth—+6.6—
EBITDA Growth—+18.3—
EBIT Growth—+25.9—
Net Income Growth—+29.4—
EPS Growth—+28.8—
Total Assets Growth—+7.9—
Total Equity Growth—+9.1—
Cash from Operations Growth—-64.0—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.